2.95

0.68% 0.02

After Hours: 2.80 -0.15 -5.08%

Alaunos Therapeutics Inc (TCRT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Alaunos Therapeutics Inc stock is traded at $2.95, with a volume of 13,536. It is up +0.68% in the last 24 hours and down -8.67% over the past month. Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Previous Close:

$2.93

Open:

$2.94

24h Volume:

13,536

Relative Volume:

0.29

Market Cap:

$6.58M

Revenue:

$6,000

Net Income/Loss:

$-3.99M

P/E Ratio:

-1.1971

EPS:

-2.4643

Net Cash Flow:

$-2.85M

1W Performance:

+1.37%

1M Performance:

-8.67%

6M Performance:

+5.06%

1Y Performance:

+63.89%

1-Day Range:

$2.90

$3.0199

1-Week Range:

$2.80

$3.05

52-Week Range:

$1.3137

$6.20

Alaunos Therapeutics Inc Stock (TCRT) Company Profile

Name

Alaunos Therapeutics Inc

Sector

Healthcare (1114)

Industry

Biotechnology (624)

Phone

(346) 355-4099

Address

501 E LAS OLAS BLVD, FORT LAUDERDALE

Employee

Twitter

Next Earnings Date

2024-12-12

Latest SEC Filings

TCRT's Discussions on Twitter

Compare TCRT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCRT Alaunos Therapeutics Inc	2.95	6.54M	6,000	-3.99M	-2.85M	-2.4643
VRTX Vertex Pharmaceuticals Inc	474.17	120.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	771.25	80.15B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	864.42	51.56B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	354.75	47.74B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	336.16	37.38B	4.98B	69.59M	525.67M	0.5197

Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-04-22	Resumed	Wells Fargo	Overweight

Alaunos Therapeutics Inc Stock (TCRT) Latest News

Jan 26, 2026

Swing Trade: Is Alaunos Therapeutics Inc a turnaround story2025 Price Targets & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Jan 26, 2026

Jan 25, 2026

Can Alaunos Therapeutics Inc stock double in the next year - baoquankhu1.vn

Jan 25, 2026

Jan 23, 2026

Is Alaunos Therapeutics Inc a cyclical or defensive stockTrade Ideas & High Accuracy Swing Trade Signals - baoquankhu1.vn

Jan 23, 2026

Jan 21, 2026

Fundamentals Check: truyen hinh quan khu mot ky 1 thang 11 ngay 11112019 1087 1July 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn

Jan 21, 2026

Published on: 2026-01-22 06:26:50 - baoquankhu1.vn

Jan 21, 2026

Jan 19, 2026

Why Alaunos Therapeutics Inc. stock could see breakout soonJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - bollywoodhelpline.com

Jan 19, 2026

Jan 15, 2026

Volume Report: Is BioSig Technologies Inc a turnaround storyJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Jan 15, 2026

Downgrade Watch: Will Alaunos Therapeutics Inc benefit from rate cutsQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn

Jan 15, 2026

Jan 10, 2026

Why Alaunos Therapeutics Inc. stock could rally in 2025Trade Analysis Report & AI Driven Price Predictions - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Market Wrap: Why Alaunos Therapeutics Inc stock is favored by pension fundsJuly 2025 Final Week & AI Optimized Trade Strategies - Bộ Nội Vụ

Jan 09, 2026

Published on: 2026-01-09 20:19:14 - Улправда

Jan 09, 2026

Jan 08, 2026

Why Alaunos Therapeutics Inc. stock is seen as undervalued2025 Price Momentum & Verified High Yield Trade Plans - Улправда

Jan 08, 2026

Will Alaunos Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Gainers & Real-Time Buy Signal Notifications - Улправда

Jan 08, 2026

Why Alaunos Therapeutics Inc. stock remains on buy listsJuly 2025 Sentiment & Short-Term High Return Ideas - Улправда

Jan 08, 2026

Bull Bear: Why Alaunos Therapeutics Inc. stock is favored by pension funds2025 Trading Volume Trends & Weekly Watchlist of Top Performers - Улправда

Jan 08, 2026

Jan 05, 2026

Retail Surge: Will Alaunos Therapeutics Inc stock maintain dividend yield2025 Dividend Review & AI Forecasted Entry and Exit Points - moha.gov.vn

Jan 05, 2026

Dec 30, 2025

Will Alaunos Therapeutics Inc stock attract more institutional investorsM&A Rumor & Accurate Entry/Exit Alerts - moha.gov.vn

Dec 30, 2025

Dec 23, 2025

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices - Investing.com Canada

Dec 23, 2025

Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer - TipRanks

Dec 23, 2025

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices By Investing.com - Investing.com South Africa

Dec 23, 2025

Dec 19, 2025

Risk Check: Can Alaunos Therapeutics Inc. stock outperform in 2025 bull market - Улправда

Dec 19, 2025

Will Alaunos Therapeutics Inc. stock maintain dividend yieldEarnings Growth Summary & Consistent Return Investment Signals - DonanımHaber

Dec 19, 2025

Will Alaunos Therapeutics Inc. stock split again soon2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber

Dec 19, 2025

Is Alaunos Therapeutics Inc. stock attractive after correctionWeekly Risk Report & Consistent Profit Trade Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

How strong is Alaunos Therapeutics Inc. stock revenue growthSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru

Dec 18, 2025

Dec 11, 2025